Bahrain and the UAE are making Pfizer’s shot available as a booster to anyone who received a Chinese vaccine

Bahrain and the UAE are making Pfizer's shot available as a booster to anyone who received a Chinese vaccine
A young woman receives a COVID-19 vaccine at the Bahrain International Exhibition and Convention Center in the capital Manama on Dec. 24, 2020. Bahrain has approved both the Pfizer/BioNTech vaccine and another developed by Chinese firm Sinopharm.

Bahrain and the United Arab Emirates (UAE) are now urging citizens who have been fully vaccinated with Chinese-made COVID-19 vaccines to receive a booster dose of the Pfizer vaccine. Simultaneously, it has been reported in Serbia that 30% of the elderly who have been immunised with Chinese vaccines have no antibodies.

More deaths and miscarriages have been reported in Hong Kong in the last week as a result of inoculation with Chinese vaccines.

Despite unfinished phase 3 trials and unreleased clinical trial data, the Chinese Communist Regime has been pushing “vaccine diplomacy” over the last year by offering Chinese-made COVID-19 vaccines to countries in the Middle East, South America, and Eastern Europe.

Serbia is the first European country to receive COVID-19 vaccines manufactured by Sinopharm, a Chinese state-owned company. According to The Wall Street Journal (WSJ), an unpublished real-world study found that 29 percent of 150 vaccine recipients in the country with an average age of over 65 did not have any antibodies against the CCP virus three months after full vaccination (two doses) with the Sinopharm vaccine.

“The Sinopharm vaccine is not immunogenic enough, and it appears that its impact is especially low on elderly recipients,” said the doctor who led the study at the University of Belgrade.

Due to a lack of relevant clinical trial data, Chinese officials previously stated that the Chinese COVID-19 vaccines are not permitted to be used on people over the age of 60 in China. However, in the countries that purchased the vaccines, the elderly are given first priority. Taiwanese media slammed the Chinese regime, alleging that it is using people in recipient countries as test subjects.

Despite having inoculated a large number of their citizens with the Sinopharm vaccine, the UAE and Bahrain are now experiencing a surge in COVID-19 infections.

So far, 47 percent of Bahrain’s population has been fully immunised, with 60 percent receiving the Sinopharm vaccine. The local epidemic, on the other hand, has not abated. The number of new infections per day increased from 200 at the end of last year when vaccinations began to 3,000 at the end of May.

The number of confirmed cases in Bahrain has reached an all-time high, and officials have been offering the Pfizer vaccine as a booster shot to those who have already been fully vaccinated with Sinopharm since the end of May.

Bahraini health officials are urging vaccinated people over the age of 50, those who are obese, or those with chronic illnesses to get the Pfizer shot as a booster.

The UAE has made the Sinopharm vaccine available to the general public since December 2020, and has been providing third Sinopharm doses since March after it was discovered that the vaccines did not produce enough antibodies for some recipients.

Gao Fu, the director of China’s Center for Disease Control and Prevention, stated in March that a third dose of Chinese-made COVID-19 vaccines may be required to increase their efficacy.

In April, the UAE began using the Pfizer vaccine, which was developed in collaboration with Germany’s BioNTech.

Aside from their low efficacy, Chinese vaccines have been linked to serious side effects.

In the last week of May, Hong Kong health officials reported that another 12 people died after receiving the Sinovac vaccine, bringing the total number of deaths to 80, and that four pregnant women miscarried after receiving the vaccine, bringing the total to 23.

Despite quality concerns and a lack of transparency in trial data and side effects, the World Health Organization recently approved both the Sinopharm and Sinovac vaccines for use in emergencies.


Please enter your comment!
Please enter your name here